There have been almost 12,000 cases of mucormycosis, commonly called ‘black fungus’, in India so far. Mucormycosis has a death rate of about 54% according to the The United States Centers for Disease Control and Prevention. Usually considered a rare disease, it is infecting those recovering from coronavirus at an unprecedented number, especially those who are diabetic. Gujarat and Maharashtra are the worst affected with almost 3,000 cases each of mucormycosis so far.
The Delhi High Court has ordered duty free import of mucormycosis medication Amphotericin B, while US-based Gilead Sciences is preparing to supply 1 million doses to India. But availability is not the only issue. The steep price of mucormycosis treatment is costing between five to fifteen lakhs per patient. Among the survivors of mucormycosis, some are losing their eyes due to the fungal infection.
On this episode of The Suno India Show, our reporter Suryatapa Mukherjee speaks to Dr Akshay Nair, an oculoplastic surgeon in Mumbai. He has been treating several cases of mucormycosis in this pandemic. We explore causes, symptoms, preventive measures and treatment. So that if you encounter a mucormycosis infection, you’ll know exactly what to do.
Mucormycosis Statistics | Mucormycosis | Fungal Diseases
National Diabetes and Diabetic Retinopathy Survey report 2015-2019